Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio #5 Cytokinetics; NMPA And FDA Approvals MYQORZO oHCM, Data For nHCM Same Drug Q2 2026, 1st Half 2026 EMA Approval Aficamten oHCM ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #5 is about a biotech by the name of Cytokinetics (CYTK). The reason why I believe that it is important ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick#18 Annovis Bio; 6-Month Path Forward Possible For Buntanetap In AD, Q1 2025 Phase 3 Study Initiation And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...